Integra Lifesciences Holdings (FRA:IL3) Total Equity : €1,470 Mil (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Integra Lifesciences Holdings Total Equity?

Integra Lifesciences Holdings's total equity for the quarter that ended in Mar. 2024 was €1,470 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Integra Lifesciences Holdings Total Equity Historical Data

The historical data trend for Integra Lifesciences Holdings's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Integra Lifesciences Holdings Total Equity Chart

Integra Lifesciences Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Equity

Get a 7-Day Free Trial

1,275.06

1,245.22

1,491.05

1,703.36

1,456.09

Integra Lifesciences Holdings Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Equity	Get a 7-Day Free Trial															1,564.39	1,553.56	1,479.73	1,456.09	1,470.12

Integra Lifesciences Holdings Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Integra Lifesciences Holdings's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2023 )	-	Total Liabilities(Q: Dec. 2023 )
	=	3468.083	-	2011.993
	=	1,456

Integra Lifesciences Holdings's Total Equity for the quarter that ended in Mar. 2024 is calculated as

Total Equity	=	Total Assets(Q: Mar. 2024 )	-	Total Liabilities(Q: Mar. 2024 )
	=	3751.966	-	2281.85
	=	1,470

Integra Lifesciences Holdings Total Equity Related Terms

Thank you for viewing the detailed overview of Integra Lifesciences Holdings's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Integra Lifesciences Holdings (FRA:IL3) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Integra Lifesciences Holdings Corp (FRA:IL3) » Definitions » Total Equity

Comparable Companies

Traded in Other Exchanges

IART:USA

Address

1100 Campus Road, Princeton, NJ, USA, 08540

Website

https://www.integralife.com

Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman specialty surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.

Integra Lifesciences Holdings (FRA:IL3) Headlines

No Headlines